These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 8621259)

  • 1. Direct killing of interleukin-2-transfected tumor cells by human neutrophils.
    Pericle F; Kirken RA; Epling-Burnette PK; Blanchard DK; Djeu JY
    Int J Cancer; 1996 May; 66(3):367-73. PubMed ID: 8621259
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Function associated with IL-2 receptor-beta on human neutrophils. Mechanism of activation of antifungal activity against Candida albicans by IL-2.
    Djeu JY; Liu JH; Wei S; Rui H; Pearson CA; Leonard WJ; Blanchard DK
    J Immunol; 1993 Feb; 150(3):960-70. PubMed ID: 8380826
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IL-2Ralpha-Directed monoclonal antibodies provide effective therapy in a murine model of adult T-cell leukemia by a mechanism other than blockade of IL-2/IL-2Ralpha interaction.
    Phillips KE; Herring B; Wilson LA; Rickford MS; Zhang M; Goldman CK; Tso JY; Waldmann TA
    Cancer Res; 2000 Dec; 60(24):6977-84. PubMed ID: 11156399
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of IL-1, IL-2, and tumor necrosis factor on polymorphonuclear leukocyte Fc gamma receptor-mediated phagocytosis. IL-2 down-regulates the effect of tumor necrosis factor.
    Moxey-Mims MM; Simms HH; Frank MM; Lin EY; Gaither TA
    J Immunol; 1991 Sep; 147(6):1823-30. PubMed ID: 1890305
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of tumor necrosis factor-alpha production from human neutrophils by IL-2 via IL-2-R beta.
    Wei S; Blanchard DK; Liu JH; Leonard WJ; Djeu JY
    J Immunol; 1993 Mar; 150(5):1979-87. PubMed ID: 8436829
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Different tumours, transduced with different cytokine genes as G-CSF and IL-2, show inhibition of tumour take through neutrophil activation but differ in T cell functions.
    Stoppacciaro A; Forni G; Colombo MP
    Folia Biol (Praha); 1994; 40(1-2):89-99. PubMed ID: 7525363
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro and in vivo characteristics of human squamous cell carcinoma of the head and neck cells engineered to secrete interleukin-2.
    Nagashima S; Reichert TE; Kashii Y; Suminami Y; Chikamatsu K; Whiteside TL
    Cancer Gene Ther; 1997; 4(6):366-76. PubMed ID: 9408607
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interleukin-2 enhances the growth of human melanoma cells derived form primary but not from metastatic tumours.
    García-Vázquez MD; Boyano MD; Cañavate ML; Gardeazabal J; de Galdeano AG; López-Michelena T; Ratón JA; Izu R; Díaz-Ramón JL; Díaz-Pérez JL
    Eur Cytokine Netw; 2000 Dec; 11(4):654-61. PubMed ID: 11125310
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fibroblasts genetically engineered to secrete interleukin 12 can suppress tumor growth and induce antitumor immunity to a murine melanoma in vivo.
    Tahara H; Zeh HJ; Storkus WJ; Pappo I; Watkins SC; Gubler U; Wolf SF; Robbins PD; Lotze MT
    Cancer Res; 1994 Jan; 54(1):182-9. PubMed ID: 7903204
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of cancer gene therapy in aging: adenocarcinoma cells engineered to release IL-2 are rejected but do not induce tumor specific immune memory in old mice.
    Provinciali M; Argentati K; Tibaldi A
    Gene Ther; 2000 Apr; 7(7):624-32. PubMed ID: 10819579
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IL-2-dependent proliferation of murine T cells requires expression of both the p55 and p70 subunits of the IL-2 receptor.
    Jankovic DL; Rebollo A; Kumar A; Gibert M; Thèze J
    J Immunol; 1990 Dec; 145(12):4136-44. PubMed ID: 2258612
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of N(G)-Nitro-L-arginine methyl ester, an inhibitor of nitric oxide synthesis, on IL-2-induced LAK cell generation in vivo and in vitro in healthy and tumor-bearing mice.
    Orucevic A; Lala PK
    Cell Immunol; 1996 Apr; 169(1):125-32. PubMed ID: 8612285
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin-2 prevention of apoptosis in human neutrophils.
    Pericle F; Liu JH; Diaz JI; Blanchard DK; Wei S; Forni G; Djeu JY
    Eur J Immunol; 1994 Feb; 24(2):440-4. PubMed ID: 7507846
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel monoclonal antibody against murine IL-2 receptor beta-chain. Characterization of receptor expression in normal lymphoid cells and EL-4 cells.
    Tanaka T; Tsudo M; Karasuyama H; Kitamura F; Kono T; Hatakeyama M; Taniguchi T; Miyasaka M
    J Immunol; 1991 Oct; 147(7):2222-8. PubMed ID: 1918958
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lack of intermediate-affinity interleukin-2 receptor in mice leads to dependence on interleukin-2 receptor alpha, beta and gamma chain expression for T cell growth.
    Chastagner P; Moreau JL; Jacques Y; Tanaka T; Miyasaka M; Kondo M; Sugamura K; Thèze J
    Eur J Immunol; 1996 Jan; 26(1):201-6. PubMed ID: 8566067
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of neutrophils and lymphocytes in inhibition of a mouse mammary adenocarcinoma engineered to release IL-2, IL-4, IL-7, IL-10, IFN-alpha, IFN-gamma, and TNF-alpha.
    Musiani P; Allione A; Modica A; Lollini PL; Giovarelli M; Cavallo F; Belardelli F; Forni G; Modesti A
    Lab Invest; 1996 Jan; 74(1):146-57. PubMed ID: 8569177
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression and functional role of the p75 interleukin 2 receptor chain on leukemic hairy cells.
    Trentin L; Zambello R; Benati C; Cassatella M; Agostini C; Bulian P; Adami F; Carra G; Pizzolo G; Semenzato G
    Cancer Res; 1992 Oct; 52(19):5223-8. PubMed ID: 1394125
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin (IL)-2 activation of p21ras in murine myeloid cells transfected with human IL-2 receptor beta chain.
    Izquierdo M; Downward J; Otani H; Leonard WJ; Cantrell DA
    Eur J Immunol; 1992 Mar; 22(3):817-21. PubMed ID: 1547824
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of interleukin (IL)-2 and IL-15 in the tumour progression of a melanoma cell line MELP, derived from an IL-2 progressor patient.
    Doucet C; Meazza R; Pottin-Clemenceau C; Scudeletti M; Brouty-Boye D; Ferrini S; Alileche A; Taoufik Y; Jasmin C; Azzarone B; Indiveri F
    Melanoma Res; 1997 Aug; 7 Suppl 2():S7-17. PubMed ID: 9578412
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Direct effects of IL-10 on subsets of human CD4+ T cell clones and resting T cells. Specific inhibition of IL-2 production and proliferation.
    de Waal Malefyt R; Yssel H; de Vries JE
    J Immunol; 1993 Jun; 150(11):4754-65. PubMed ID: 7684412
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.